Compare Super Micro Computer Inc (SMCI) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Super Micro Computer Inc vs TG Therapeutics Inc — how do they compare? Super Micro Computer Inc trades at $41.8 (market cap $28.10B), while TG Therapeutics Inc trades at $55.24 (market cap $8.16B). The key difference: Super Micro Computer Inc is far larger — about 3.4× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Super Micro Computer Inc for 19 Days and TG Therapeutics Inc for 16 Days on average.
| SMCI | TGTX | |
|---|---|---|
Market Cap | $28.10B | $8.16B |
Volume | 38,581,805 | 1,735,121 |
Sector | Technology | Health |
52-Week High | $57.98 | $59.06 |
52-Week Low | $20.53 | $26.94 |
Typical Hold Time | 19 Days | 16 Days |
Enterprise Value | $33.56B | $8.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Super Micro Computer (SMCI) trades at $41.34, down 8.03% in the last session, but maintains strong fundamental performance with consistent earnings beats and robust revenue growth projections. The stock shows bullish technical signals with support at $40 and resistance at $44, while valuation metrics remain attractive with a P/E of 13.12 and P/S of 0.76. Recent news highlights AI server demand growth and new NVIDIA Vera Rubin platform shipments.
SMCI presents a compelling value opportunity with strong AI-driven growth prospects, though investors face risks from competitive pressures and potential regulatory scrutiny. Analyst consensus leans neutral with a $42.33 price target, while institutional interest remains strong given the company's positioning in the expanding AI infrastructure market.
TG Therapeutics (TGTX) trades at $54.80, up 3.49% today, but faces a bearish technical signal with recent earnings misses. Revenue growth is strong, with 2026 guidance raised to $950M for BRIUMVI, and net income margins exceed 55%. However, cash flow was negative in 2025, and a shareholder litigation investigation adds near-term uncertainty.
The outlook is mixed: analyst consensus is bullish with an $80.50 price target, but execution risks and earnings volatility persist. Upside hinges on BRIUMVI market share gains and subcutaneous formulation progress, while legal and competitive pressures pose threats to shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
